Chapter 8.C.3 (or 6.C.1).  Testing, Reporting, and Contact Tracing


Notes: Testing Programs


Note 1. Voluntary Screening.


For recent developments in newborn screening programs, see Amy Harmon, As Gene Test Menu Grows, Who Gets to Choose?, The New York Times, July 21, 2004, at A1, col.1. Available:  (last visited July 20, 2006).


For a discussion about HIV screening see Paltiel et. al., Expanded Screening for HIV in the United States An Analysis of Cost-Effectiveness, 352 N Engl J Med 586 (2005); see also, Samuel Bossette, Routine Screening for HIV Infection Timely and Cost-Effective, 352 N Engl J Med 620 (2005).


Note 5. Mandatory Screening


For a discussion of issues related to immigration, see Amy L. Fairchild, Policies of Inclusion: Immigrants, Disease, Dependency, and American Immigration Policy at the Dawn and Dusk of the 20th Century, 94 Am J Public Health 528 (2004).


Problem: HIV Screening for Pregnant Women and Newborns


See, Doe v. Division of Youth and Family Services, 148 F.Supp.2d 462 (D.N.J. 2001) (complaint alleging improper HIV testing of pregnant woman along with effort to coerce perinatal antiretroviral therapy).


See, Leslie Wolf, Bernard Lo, & Lawrence Gostin, Legal Barriers to Implementing Recommendations for Universal, Routine Prenatal HIV Testing, 32 J L Med & Ethics 137 (2004).


Notes: Reporting and Contact Tracing


Problem: Bioterrorism, Reporting and Contact Tracing


See, Lawrence Gostin, When Terrorism Threatens Health: How far are Limitations on Personal and Economic Liberties Justified? 55 Fla L Rev 1105 (2003).